Skip to content
Menu
Find Partners
Ion Channel World Map
Companies
Labs
Nonprofits
Resources
Ion Channel Overview
Fundamentals
Ion Channel Drugs
Interviews
Analytics
Expert opinions
Books
Infographics
Journal Covers
Quotes
External Resources
Blog
Menu
Find Partners
Ion Channel World Map
Companies
Labs
Nonprofits
Resources
Ion Channel Overview
Fundamentals
Ion Channel Drugs
Interviews
Analytics
Expert opinions
Books
Infographics
Journal Covers
Quotes
External Resources
Blog
Industry
-
08/06/2022
Newron shows encouraging results for evenamide (Nav channel inhibitor) in patients with treatment-resistant schizophrenia
Source: Newron Pharmaceuticals
Industry
-
17/12/2020
Cadent Therapeutics and its ion channel programs to be acquired by Novartis
Industry
-
07/11/2020
Saniona regains GABAa5 negative allosteric modulator program from Boehringer Ingelheim
